Entry |
|
Name |
Afimoxifene (USAN/INN); Tamogel (TN) |
Formula |
C26H29NO2
|
Exact mass |
387.2198
|
Mol weight |
387.51
|
Structure |
|
Simcomp |
|
Class |
Antineoplastic
DG01585 Estrogen receptor antagonist
DG01620 Tamoxifene-type antineoplastic
Hormonal agent
DG01619 Estrogen receptor antagonist/modulator
|
Efficacy |
Antineoplastic |
Comment |
Selective estrogen receptor modulators (SERMs)
Local treatment of estrogen dependent conditions of the breast
|
Target |
|
Pathway |
|
Brite |
Drug groups [BR:br08330]
Antineoplastic
DG01585 Estrogen receptor antagonist
DG01620 Tamoxifene-type antineoplastic
D06551 Afimoxifene
Hormonal agent
DG01619 Estrogen receptor antagonist/modulator
D06551 Afimoxifene
Target-based classification of drugs [BR:br08310]
Nuclear receptors
Estrogen like receptors
Estrogen receptor
NR3A (ESR)
D06551 Afimoxifene (USAN/INN)
|
Other DBs |
|
LinkDB |
|
KCF data |
ATOM 29
1 C8x C 13.0900 -17.2900
2 C8y C 13.0900 -18.6900
3 C8x C 14.3024 -19.3900
4 C8x C 15.5149 -18.6900
5 C8y C 15.5149 -17.2900
6 C8x C 14.3024 -16.5900
7 C8x C 17.9397 -18.6900
8 C8y C 17.9397 -17.2900
9 C2c C 16.7273 -16.5900
10 C8x C 19.1522 -19.3900
11 C8y C 20.3646 -18.6900
12 C8x C 20.3646 -17.2900
13 C8x C 19.1522 -16.5900
14 C2c C 16.7273 -15.1900
15 O1a O 11.8776 -19.3900
16 C8y C 17.9418 -14.4888
17 C1b C 15.5169 -14.4912
18 C1a C 14.3045 -15.1912
19 O2a O 21.5811 -19.3923
20 C1b C 22.7786 -18.7008
21 C1b C 23.9649 -19.3857
22 N1c N 25.1567 -18.6974
23 C1a C 26.3459 -19.3839
24 C1a C 25.1567 -17.2903
25 C8x C 19.1383 -15.1798
26 C8x C 20.3508 -14.4799
27 C8x C 20.3509 -13.0799
28 C8x C 19.1544 -12.3890
29 C8x C 17.9419 -13.0888
BOND 31
1 1 2 2
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 2
6 1 6 1
7 7 8 1
8 8 9 1
9 5 9 1
10 7 10 2
11 10 11 1
12 11 12 2
13 12 13 1
14 8 13 2
15 9 14 2
16 2 15 1
17 14 16 1
18 14 17 1
19 17 18 1
20 11 19 1
21 19 20 1
22 20 21 1
23 21 22 1
24 22 23 1
25 22 24 1
26 16 25 2
27 25 26 1
28 26 27 2
29 27 28 1
30 28 29 2
31 16 29 1
|